💥NEW RESEARCH PAPER💥 Our collaborative work led by Ryan Mewis w/MattHulme Jack Marron, Stuart Langley & Sophie Benjamin (NTUScienceTechnology) on the synthesis & crystal structures of 5 fluorinated diphenidine derivatives is available online Acta Cryst E journals.iucr.org/e/issues/2025/…

💥DRUG FOCUS REPORT💥 The GMTRENDS focus report on “ketamine” trends, covering 2023/24, is available (for free) online. This collaborative work, led by by Rob Ralphs, includes detailed chemical analysis by our team of scientists. Link (free): gmtrends.mmu.ac.uk/wp-content/upl…

💥NEW RESEARCH PAPER💥 Our collaborative work w/ University of Bath, led by Richard Bowman @StephenHusbands & Christopher Pudney, on a field-portable device for detection of controlled & psychoactive substances in e-cigarettes has been published in ACSOmega doi.org/10.1021/acsome…

💥BREAKING!💥25 Mar 2025 We’re proud to announce that our PUBLIC FUNDING has been renewed! Further funding to be announced soon! We’re honoured to CONTINUE to deliver our nationally-recognised harm reduction partnership and safeguard the 2.8M residents of Greater Manchester!

⛔️CAUTION!⛔️ 27 Mar 2025 Multiple, Blue “Moncler” embossed #Ecstasy tablets analytically confirmed by MANDRAKE, to contain #MDMA (average: 277 mg/tablet) = to 3x the common oral dose circulating in #Manchester. If unwell please seek medical attention.

⚠️WARNING!⚠️ 29 Mar 25 Multiple samples of beige powder, potentially mis-sold as MDMA, confirmed by MANDRAKE, to contain synthetic cathinone, 4F-α-PVP, in #Manchester Not much known about this substance but has been implicated fatalities. If unwell seek medical attention.

💥TESTING DATA💥 Mar 2025 A quick snapshot of recent MANDRAKE testing data, of frequently encountered “Ecstasy” pill/tablet types, from across Greater Manchester’s NTE venues. MDMA (as salt) content was determined by GCMS using primary reference std & expressed in mg/tab.

Heartfelt congratulations Emily on successfully completing your #Masters by #Research. Well done! The entire team wishes you all the best for the future. You will be missed.

💥NEW RESEARCH PAPER💥 Our collaborative work w/ University of Bath led by Richard Bowman Tom SF Haines & Christopher Pudney on field-portable technology for illicit drug discrimination via deep learning of hybridized spectroscopic fingerprints has been published in ACS Analytical Chemistry Journals doi.org/10.1021/acs.an…

Great to see Molly’s research on #synthetic #cannabinoid analysis - in collaboration with Shimadzu & Shimadzu UK Limited - get showcased at this prestigious #international conference. Proud to continue our strong industrial partnership. Well done all!

💥BREAKING!💥4 June 25 The team is #proud to announce that our #PUBLIC #FUNDING has been renewed. Our #scientists are honoured to continue to safeguard the 1.1M residents, across Tyne & Wear, and reduce drug-related harms through our nationally-recognised #harmreduction model.

🚨 Four potent synthetic opioids are now under international control: 1. N-pyrrolidino protonitazene 2. N-pyrrolidino metonitazene 3. Etonitazepipne 4. N-desethyl isotonitazene Controls took effect 9 June. HHC & carisoprodol follow in Dec. Read more here: bit.ly/4e25Ifk

Our Director Dr Oliver Sutcliffe spoke about rapid, cost-effective chemical analysis to monitor drug trends & promote harm reduction ISSDP Conference in Manchester Also the team were honoured to host a delegation of international attendees at our labs mmu.ac.uk/news-and-event…

💥NEW RESEARCH PAPER💥 Our international collaboration w/ Shimadzu UK Limited & the Forensic Science PSU Penn State university on the development of RP-UHPLC & HILIC approaches to the analysis of regioisomeric fluorofentanyl derivatives is now available (free) online: sciencedirect.com/science/articl…